Nationwide
A Clinical Study of MK-4082 in Healthy Overweight Participants (MK-4082-002)
Merck Sharp & Dohme LLC
Ph 1·5 sites in CA, FL, MO +1
Enrolling now
Check if I qualifyShowing 1–24 of 307 trials
Merck Sharp & Dohme LLC
Mirador Therapeutics, Inc.
Mirador Therapeutics, Inc.
Monte Rosa Therapeutics, Inc
AbbVie
Cerus Corporation
Novo Nordisk A/S
Scholar Rock, Inc.
Merck Sharp & Dohme LLC
Blueprint Medicines Corporation
Eli Lilly and Company
Eli Lilly and Company